Moore Capital Management’s BioAmber Inc. BIOA Stock Holding History

Moore Capital Management’s Portfolio BIOA Stock Details BIOA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-255,000	Closed	-$543K	–	635
2014 Q1	$543K	Buy	+255,000	New	+$3.02M	0.01%	348
2013 Q3	–	Sell	-302,500	Closed	-$2.06M	–	459
2013 Q2	$2.06M	Buy	+302,500	New	+$2.25M	0.05%	209

Other funds holding BIOA

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

ACPU

Arrowgrass Capital Partners (US) Dover, Delaware $380M AUM 20.87% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

LCS

Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

NIMI

Natixis Investment Managers International Paris, France $1.29B AUM 24.83% 1-Year Est. Return

Moore Capital Management's BIOA Position: Q2 2014 in Review

Moore Capital Management sold out of BioAmber Inc. (BIOA) in Q2 2014, closing a stake of 255,000 shares — an estimated $543K sold.

Moore Capital Management first reported a position in BIOA in Q2 2013 and held it in 2 quarters. The position peaked at $2.06M in Q2 2013. 24 funds tracked by Wall St. Rank hold BIOA as of Q2 2014.

Moore Capital Management reported no remaining BioAmber Inc. position as of Q2 2014 after selling out during the quarter.
Moore Capital Management sold 255,000 BioAmber Inc. shares in Q2 2014, an estimated $543K.
Moore Capital Management first reported a position in BioAmber Inc. in Q2 2013 and held it in 2 quarters.
Moore Capital Management's BioAmber Inc. position peaked at $2.06M in Q2 2013.
24 funds tracked by Wall St. Rank held BioAmber Inc. as of Q2 2014.

Based on Moore Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.